For Doctors in a Hurry
- Clinicians often question whether biological sex influences neurological recovery and mortality rates following a cardiac arrest.
- The study analyzed 944 patients with a mean age of 62 years to evaluate sex-based clinical differences.
- Women showed lower favorable neurological outcomes at 39.6 percent compared to 48.0 percent for men, p=0.013.
- The researchers concluded that sex is not independently associated with mortality or functional recovery after adjusting for variables.
- Physicians should attribute observed outcome disparities to underlying cardiac arrest characteristics rather than patient sex alone.
Dissecting Sex-Based Disparities in Post-Arrest Recovery
Optimizing outcomes after out-of-hospital cardiac arrest remains a significant challenge for intensive care and emergency departments, particularly regarding neurological preservation. Current management strategies emphasize rapid vascular access and the administration of epinephrine to improve survival; however, while epinephrine increases 30-day survival, it has been associated with increased rates of severe neurological impairment compared to placebo [1]. Meta-analyses of vascular access routes indicate that while randomized trials show no significant difference between intraosseous access (delivery through the bone marrow) and intravenous access (delivery through the vein), observational data suggest intraosseous access may be inversely associated with favorable neurological outcomes [2]. Although therapeutic hypothermia (the intentional reduction of core body temperature to 32 to 34 degrees Celsius to mitigate cerebral injury) has historically been utilized in comatose survivors, the influence of patient-specific factors on long-term recovery is still being elucidated [3]. Clinical guidelines for related cardiovascular conditions, such as atrial fibrillation and acute coronary syndromes, increasingly emphasize the importance of individualized risk assessment to tailor therapy [4, 5, 6]. A new cohort study now examines how biological sex interacts with these established prognostic variables to influence functional survival.
Clinical Presentation and Biomarker Profiles
The study analyzed a cohort of 944 patients with a mean age of 62 ± 15 years to determine how sex influences clinical trajectories after cardiac arrest. Within this population, 28.6% were women. Upon initial assessment, the researchers observed distinct differences in the clinical presentation of female patients compared to their male counterparts. Specifically, women more often presented with a non-cardiac etiology of arrest, indicating that the precipitating event was less likely to be primary coronary or structural heart disease. Furthermore, women more often presented with a non-shockable initial rhythm, such as asystole or pulseless electrical activity. These clinical states are traditionally associated with lower rates of successful resuscitation and poorer neurological recovery because they often reflect a longer period of untreated ischemia or a non-cardiac primary cause. Objective assessments of neurological status further distinguished the female cohort during the post-arrest period. The researchers found that women exhibited more malignant electroencephalogram (EEG) patterns, which are specific electrical brain wave abnormalities that indicate severe, diffuse cerebral dysfunction. Additionally, women more often exhibited absent somatosensory evoked potentials (SSEP), a diagnostic finding where the brain fails to produce electrical signals in response to physical stimuli, often serving as a marker for irreversible cortical damage. These electrophysiological findings were corroborated by biochemical data; specifically, women exhibited higher serum neuron-specific enolase (NSE) levels. As a protein biomarker released into the bloodstream during neuronal injury, elevated NSE concentrations provide a quantitative measure of the extent of brain damage sustained during and after the arrest event, helping clinicians estimate the degree of hypoxic-ischemic encephalopathy.
Adjusting for Baseline Arrest Characteristics
The raw clinical data initially suggested a notable disparity in recovery between the sexes, as favorable neurological outcome occurred in 39.6% of women compared to 48.0% of men. This 8.4% difference in unadjusted favorable neurological outcomes was statistically significant with a p-value of 0.013, suggesting on the surface that female patients might face an inherently poorer prognosis following cardiac arrest. These findings align with the observation that women presented with worse unadjusted outcomes and more severe prognostic profiles, including the higher levels of neuronal injury markers and more frequent non-shockable rhythms noted during their initial clinical assessments. However, when the researchers applied multivariable adjustment (a statistical process used to isolate the effect of one variable by controlling for other confounding factors), the apparent influence of biological sex disappeared. The analysis revealed that sex was not independently associated with ICU mortality, yielding an odds ratio (OR) of 1.08 (95% CI: 0.80-1.46). Similarly, there was no independent link between sex and 3-month mortality, which showed an OR of 1.05 (95% CI: 0.77-1.43). Most critically for long-term recovery, the study found that sex was not independently associated with favorable functional outcome, with an OR of 1.00 (95% CI: 0.73-1.37) after adjusting for confounding clinical variables. For the practicing clinician, these results clarify that the observed outcome differences likely reflect less favorable underlying cardiac arrest characteristics rather than biological sex itself. While women in this cohort often presented with more challenging clinical profiles, such as non-cardiac causes of arrest, their physiological capacity for neurological recovery was comparable to men when starting from similar clinical baselines. These findings suggest that prognostications should remain focused on the specific circumstances of the arrest and the resulting neurological markers rather than the patient's sex, ensuring that clinical decisions regarding the intensity of care are based on objective injury severity.
References
1. Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. New England Journal of Medicine. 2018. doi:10.1056/nejmoa1806842
2. Song Q, Liu R, Yang K, et al. Efficacy of intraosseous access for non-traumatic out-of-hospital cardiac arrest: A meta-analysis of randomised controlled trials and propensity-score matched studies. Journal of the Renin-Angiotensin-Aldosterone System. 2025. doi:10.1177/14703203251338177
3. Bernard S, Gray TW, Buist M, et al. Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia. New England Journal of Medicine. 2002. doi:10.1056/nejmoa003289
4. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020. doi:10.1093/eurheartj/ehaa612
5. Collet J, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2020. doi:10.1093/eurheartj/ehaa575
6. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023. doi:10.1161/cir.0000000000001193
